These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 370990)

  • 1. Amniotic fluid antibacterial mechanisms: newer concepts.
    Schlievert P; Johnson W; Galask RP
    Semin Perinatol; 1977 Jan; 1(1):59-70. PubMed ID: 370990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial growth inhibition by amniotic fluid. VII. The effect of zinc supplementation on bacterial inhibitory activity of amniotic fluids from gestation of 20 weeks.
    Schlievert P; Johnson W; Galask RP
    Am J Obstet Gynecol; 1977 Mar; 127(6):603-8. PubMed ID: 842586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of transferrin and lysozyme on antibacterial activity of amniotic fluid.
    Oka K; Hagio Y; Tetsuoh M; Kawano K; Hamada T; Kato T
    Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):1-6. PubMed ID: 3107622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the antibacterial property of amniotic fluid by hyperthermia.
    Larsen B; Davis B
    Obstet Gynecol; 1984 Mar; 63(3):425-9. PubMed ID: 6366661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial growth inhibition by amniotic fluid. VIII. Evaluation of a radiometric bioassay for rapid, in vitro demonstration of phosphate-sensitive bacterial growth inhibitor in amniotic fluid.
    Larsen B; Cheng HF; Galask RP
    Am J Obstet Gynecol; 1979 Sep; 135(1):14-21. PubMed ID: 382854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sexually transmitted microorganisms and immunoglobulins in the amniotic fluid in mothers who carry sexually transmitted diseases].
    Bernal JN; Martínez MA; Sepúlveda C; Suárez M; Triantafilo Y; Jankelevich J; Romero C; Espinza A
    Rev Chil Obstet Ginecol; 1992; 57(4):273-8. PubMed ID: 1342452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial growth inhibition by amniotic fluid. IV. Studies on the nature of bacterial inhibition with the use of plate-count determinations.
    Schlievert P; Larsen B; Johnson W; Galask RP
    Am J Obstet Gynecol; 1975 Aug; 122(7):814-9. PubMed ID: 1096617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of gas-liquid chromatography in the detection of intra-amniotic microbial invasion.
    Romero R; Scharf K; Mazor M; Emamian M; Hobbins JC; Ryan JL
    Obstet Gynecol; 1988 Jul; 72(1):44-50. PubMed ID: 3380509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial activity of amniotic fluid and lysozyme].
    Hagio Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2369-75. PubMed ID: 3935742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Causes of the antibacterial action of amniotic fluid (author's transl)].
    Dickgiesser N; Hohlweg-Majert P; Wuthe J
    Geburtshilfe Frauenheilkd; 1981 Jul; 41(7):504-8. PubMed ID: 6790329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of amniotic fluid on bacteria].
    Kalamaras E; Karanfilska N; Dzikov Z; Kalamaras A
    Jugosl Ginekol Opstet; 1980; 19(3-4):139-44. PubMed ID: 7412369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacteriologic studies of the amniotic fluid following amniocentesis].
    Lettau R; Klink F; Oberheuser F; Marre R
    Z Geburtshilfe Perinatol; 1986; 190(6):256-60. PubMed ID: 3551360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amniotic fluid and neonatal infection].
    Aujard Y
    Pediatrie; 1986 Mar; 41(2):109-13. PubMed ID: 3774421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial degradation of immunoglobulin A1 in relation to periodontal diseases.
    Grønbaek Frandsen EV
    APMIS Suppl; 1999; 87():1-54. PubMed ID: 10189832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host defense proteins in vernix caseosa and amniotic fluid.
    Akinbi HT; Narendran V; Pass AK; Markart P; Hoath SB
    Am J Obstet Gynecol; 2004 Dec; 191(6):2090-6. PubMed ID: 15592296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies.
    Jaspan HB; Robinson JE; Amedee AM; Van Dyke RB; Garry RF
    J Clin Virol; 2004 Nov; 31(3):190-7. PubMed ID: 15465411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum.
    Bucki R; Sostarecz AG; Byfield FJ; Savage PB; Janmey PA
    J Antimicrob Chemother; 2007 Sep; 60(3):535-45. PubMed ID: 17584802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial and antimycotic activity of the amniotic fluid against selected germs (author's transl)].
    Jankowski RP; Rauskolb R; Gupta KG
    Geburtshilfe Frauenheilkd; 1977 Mar; 37(3):232-4. PubMed ID: 404210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Armadillidin: a novel glycine-rich antibacterial peptide directed against gram-positive bacteria in the woodlouse Armadillidium vulgare (Terrestrial Isopod, Crustacean).
    Herbinière J; Braquart-Varnier C; Grève P; Strub JM; Frère J; Van Dorsselaer A; Martin G
    Dev Comp Immunol; 2005; 29(6):489-99. PubMed ID: 15752546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes.
    Wiese A; Gutsmann T; Seydel U
    J Endotoxin Res; 2003; 9(2):67-84. PubMed ID: 12803879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.